How Tandem Diabetes Care Blew Past Wall Street Estimates in Q3
In February, I picked Tandem Diabetes (NASDAQ: TNDM) as my top diabetes stock to watch. Little did I know at the time just how exciting this stock would be. Its shares had soared nearly 48% year to date heading into its third-quarter update.
Tandem announced its Q3 results after the market closed on Monday. And investors yet again had reasons to be excited about the company's performance. Here are the highlights from Tandem's Q3 results.
Image source: Getty Images.
Source Fool.com
